Astrazeneca (AZN) rejected 78 million British pounds ($96.4 million) of UK government support after the new administration sought to reduce the amount of public support the company was promised by the previous administration to build a vaccine manufacturing facility, according to Financial Times, citing people briefed on the matter.
AstraZeneca said Friday that it was canceling plans to invest 450 million pounds in a vaccine manufacturing facility in Speke, England, which it attributed to the cut in government funding support.
The previous government had offered the pharmaceutical company 90 million pounds, which includes 70 million pounds in grants for the factory and 20 million pounds in research and development support from the UK Health Security Agency, the FT reported.
AstraZeneca did not immediately respond to a request for comment from MT Newswires.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。